Physician profile
Mark W Morgan
NPI 1275535072
$23,425.20
in general payments reported to CMS, 2019-2025
11 companies · $2,263 in 2025
The $2,263 reported for 2025 was more than what 85% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,405 · 2020: $3,551 · 2021: $478 · 2022: $688 · 2023: $4,436 · 2024: $3,604 · 2025: $2,263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,374 · Food and Beverage: $1,929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,374.12 |
| Food and Beverage | $1,929.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $12,999.56 | 2019-2022 | |
| Abbvie INC. | $9,491.07 | 2023-2025 | |
| Motiva USA, LLC | $572.88 | 2025 | |
| Rti Surgical, INC | $124.06 | 2023 | |
| Mentor Worldwide LLC | $98.75 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Ethicon US, LLC | $43.71 | 2022 | |
| Polynovo North America LLC | $24.69 | 2022 | |
| Sientra, INC. | $18.42 | 2022 | |
| Endo Pharmaceuticals INC. | $17.97 | 2021 | |
| Merz North America, INC. | $17.40 | 2021 | |
| Integra Lifesciences Corporation | $16.69 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.